Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1363, 2002-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Early interferon-β-1b of BENEFIT for MS?
Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. :
Access to resources
Recommend
Laquinimod beneficial in relapsing-remitting MS?
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
Atorvastatin: promising new therapy for MS?
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
IFN- -1b has greater bioactivity than IFN- -1a in MS?
Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. :
Statins: stick to the status quo?
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :